Sophiris Bio, Inc.
(Other OTC/NBB : SPHS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 2.86%310.110.0%$5220.21m
BNTXBioNTech SE 3.21%344.200.0%$1581.96m
NVAXNovavax, Inc. -0.61%160.9878.2%$852.29m
AMGNAmgen, Inc. 0.63%202.431.4%$596.96m
GILDGilead Sciences, Inc. -0.20%69.531.0%$508.76m
VRTXVertex Pharmaceuticals, Inc. -0.63%203.161.9%$475.98m
REGNRegeneron Pharmaceuticals, Inc. -1.00%627.672.7%$469.30m
LGVNLongeveron Inc. 18.61%21.350.0%$425.78m
ILMNIllumina, Inc. -2.97%346.853.3%$315.59m
SNSSSunesis Pharmaceuticals, Inc. -2.80%4.160.7%$290.80m
BIIBBiogen, Inc. -2.26%223.351.8%$272.68m
OCGNOcugen, Inc. -9.00%5.740.0%$192.62m
INCYIncyte Corp. -1.46%65.662.4%$153.95m
EXASEXACT Sciences Corp. -5.31%76.2918.0%$147.76m
SGENSeagen Inc. -4.76%151.125.8%$144.19m

Company Profile

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.